In a recent survey by the Central Drug Standards Control Organisation (CDSCO), over 50 commonly prescribed medications, including those for high blood pressure, acid reflux, and erectile dysfunction, were found to be of substandard quality.
Despite failing to meet safety and efficacy standards, these drugs remain available in the market.
Top pharmaceutical companies under investigation
However, Sun Pharmaceuticals denied responsibility for the batch, stating it was counterfeit. Similarly, a batch of Pantocid, a widely used acid reflux medication, was also identified as fake, the report said.
Glenmark Pharmaceuticals also came under scrutiny after a batch of Telma H (Telmisartan 40 mg and Hydrochlorothiazide 12.5 mg tablets IP), used for treating high blood pressure, was flagged. Glenmark similarly denied manufacturing the questionable batch. Additionally, Alkem Health Science faced issues with a batch of Clavam 625 (Amoxicillin and Potassium Clavulanate tablets IP), which failed to meet the required standards, the report said.
CDSCO reassures drug safety
The report quoted a senior CDSCO official as saying that a substandard result for a specific drug batch does not imply all drugs of the same name are of poor quality. The official further explained that quality concerns are regularly monitored, and issues are addressed promptly to mitigate public health risks, the report said.
Steps to enhance drug quality
(With agency inputs)
First Published: Sep 26 2024 | 4:40 PM IST
